Literature DB >> 3379433

Familial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyretin.

M Tanaka1, S Hirai, E Matsubara, K Okamoto, M Morimatsu, M Nakazato.   

Abstract

A 47 year old woman with familial amyloidotic polyneuropathy (FAP) is reported, without familial occurrence of the disease. Her 81 year old mother and 53 year old sister were proved to be asymptomatic carriers for variant transthyretin (TTR) by means of the radioimmunoassay. It is suggested that unknown factor(s) may play a role in preventing or delaying the onset of the disease, producing variations in sex and family incidence. In order to establish the diagnosis of non-hereditary primary amyloidotic polyneuropathy, it must be confirmed that variant TTR is absent in the serum of relatives.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379433      PMCID: PMC1032978          DOI: 10.1136/jnnp.51.4.576

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Polyneuritic amyloidosis in a Japanese family.

Authors:  S Araki; S Mawatari; M Ohta; A Nakajima; Y Kuroiwa
Journal:  Arch Neurol       Date:  1968-06

2.  Polymorphism of human plasma thyroxine binding prealbumin.

Authors:  F E Dwulet; M D Benson
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

3.  Studies on familial amyloid polyneuropathy in Ogawa Village, Japan.

Authors:  S Kito; E Itoga; K Kamiya; T Kishida; Y Yamamura
Journal:  Eur Neurol       Date:  1980       Impact factor: 1.710

4.  Familial amyloidotic polyneuropathy diagnosed by cloned human prealbumin cDNA.

Authors:  S Mita; S Maeda; M Ide; T Tsuzuki; K Shimada; S Araki
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

5.  A new method to classify amyloid fibril proteins.

Authors:  T Kitamoto; J Tateishi; K Hikita; H Nagara; I Takeshita
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy.

Authors:  M J Saraiva; P P Costa; D S Goodman
Journal:  Neurology       Date:  1986-11       Impact factor: 9.910

7.  Radioimmunoassay for detecting abnormal prealbumin in the serum for diagnosis of familial amyloidotic polyneuropathy (Japanese type).

Authors:  M Nakazato; K Kangawa; N Minamino; S Tawara; H Matsuo; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1984-07-31       Impact factor: 3.575

8.  Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type).

Authors:  S Tawara; M Nakazato; K Kangawa; H Matsuo; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

9.  Diagnostic radioimmunoassay for familial amyloidotic polyneuropathy before clinical onset.

Authors:  M Nakazato; T Kurihara; S Matsukura; K Kangawa; H Matsuo
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

  9 in total
  2 in total

1.  Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants.

Authors:  Olgica Trenchevska; Elena Kamcheva; Dobrin Nedelkov
Journal:  Proteomics       Date:  2011-08-09       Impact factor: 3.984

2.  Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity.

Authors:  Gonçalo da Costa; Ricardo A Gomes; Ana Guerreiro; Élia Mateus; Estela Monteiro; Eduardo Barroso; Ana V Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.